Plerixafor Injection — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Plerixafor Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on 03/13/2026.

Shortage Details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
65219-284-12
Dosage Form
Injection
Presentation
Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)
Initial Posting
03/13/2026
Revised Date